178 related articles for article (PubMed ID: 19017759)
21. MAGE-1, GAGE-1/-2 gene expression in FNAB of classic variant of papillary thyroid carcinoma and papillary hyperplasia in nodular goiter.
Ruschenburg I; Kubitz A; Schlott T; Korabiowska M; Droese M
Int J Mol Med; 1999 Oct; 4(4):445-8. PubMed ID: 10493989
[TBL] [Abstract][Full Text] [Related]
22. Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.
Liyanarachchi S; Wojcicka A; Li W; Czetwertynska M; Stachlewska E; Nagy R; Hoag K; Wen B; Ploski R; Ringel MD; Kozłowicz-Gudzinska I; Gierlikowski W; Jazdzewski K; He H; de la Chapelle A
Thyroid; 2013 Dec; 23(12):1532-40. PubMed ID: 23659773
[TBL] [Abstract][Full Text] [Related]
23. P2X7 gene polymorphisms and risk assessment for pulmonary tuberculosis in Asian Indians.
Sambasivan V; Murthy KJ; Reddy R; Vijayalakshimi V; Hasan Q
Dis Markers; 2010; 28(1):43-8. PubMed ID: 20164546
[TBL] [Abstract][Full Text] [Related]
24. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
25. The effect of TP53 and P21 gene polymorphisms on papillary thyroid carcinoma susceptibility and clinical/pathological features.
Heidari Z; Harati-Sadegh M; Arian A; Maruei-Milan R; Salimi S
IUBMB Life; 2020 May; 72(5):922-930. PubMed ID: 31895498
[TBL] [Abstract][Full Text] [Related]
26. A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population.
Kim SK; Park HJ; Hong IK; Chung JH; Eun YG
Endocrine; 2013 Feb; 43(1):161-9. PubMed ID: 23124277
[TBL] [Abstract][Full Text] [Related]
27. Lack of association of 1513 A/C polymorphism in P2X7 gene with susceptibility to pulmonary and extrapulmonary tuberculosis.
Ozdemir FA; Erol D; Konar V; Yüce H; Kara Şenli E; Bulut F; Deveci F
Tuberk Toraks; 2014; 62(1):7-11. PubMed ID: 24814072
[TBL] [Abstract][Full Text] [Related]
28. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
[TBL] [Abstract][Full Text] [Related]
29. Bipolar disorder and 1513A>C P2RX7 polymorphism frequency.
Gubert C; Andrejew R; Jacintho Moritz CE; Dietrich F; Vasconcelos-Moreno MP; Dos Santos BTMQ; Fijtman A; Kauer-Sant'Anna M; Kapczinski F; da Silva Magalhães PV; Battastini AMO
Neurosci Lett; 2019 Feb; 694():143-147. PubMed ID: 30521946
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
Meng XY; Zhang Q; Li Q; Lin S; Li J
J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
[TBL] [Abstract][Full Text] [Related]
32. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
Trovisco V; Soares P; Preto A; de Castro IV; Lima J; Castro P; Máximo V; Botelho T; Moreira S; Meireles AM; Magalhães J; Abrosimov A; Cameselle-Teijeiro J; Sobrinho-Simões M
Virchows Arch; 2005 Jun; 446(6):589-95. PubMed ID: 15902486
[TBL] [Abstract][Full Text] [Related]
33. BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma.
Gu LQ; Li FY; Zhao L; Liu Y; Zang XX; Wang TX; Chen HP; Ning G; Zhao YJ
Thyroid; 2009 Apr; 19(4):347-54. PubMed ID: 19355825
[TBL] [Abstract][Full Text] [Related]
34. Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies.
Cipriani NA; Agarwal S; Dias-Santagata D; Faquin WC; Sadow PM
Thyroid; 2017 Jun; 27(6):819-824. PubMed ID: 28293986
[TBL] [Abstract][Full Text] [Related]
35. The effect of P2X7 receptor 1513 polymorphism on susceptibility to tuberculosis: A meta-analysis.
Wu G; Zhao M; Gu X; Yao Y; Liu H; Song Y
Infect Genet Evol; 2014 Jun; 24():82-91. PubMed ID: 24650918
[TBL] [Abstract][Full Text] [Related]
36. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis.
Fernando SL; Saunders BM; Sluyter R; Skarratt KK; Goldberg H; Marks GB; Wiley JS; Britton WJ
Am J Respir Crit Care Med; 2007 Feb; 175(4):360-6. PubMed ID: 17095747
[TBL] [Abstract][Full Text] [Related]
37. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
[TBL] [Abstract][Full Text] [Related]
38. BRAF mutations in an Italian cohort of thyroid cancers.
Fugazzola L; Mannavola D; Cirello V; Vannucchi G; Muzza M; Vicentini L; Beck-Peccoz P
Clin Endocrinol (Oxf); 2004 Aug; 61(2):239-43. PubMed ID: 15272920
[TBL] [Abstract][Full Text] [Related]
39. P2X7 receptor gene polymorphism analysis in rheumatoid arthritis.
Al-Shukaili A; Al-Kaabi J; Hassan B; Al-Araimi T; Al-Tobi M; Al-Kindi M; Al-Maniri A; Al-Gheilani A; Al-Ansari A
Int J Immunogenet; 2011 Oct; 38(5):389-96. PubMed ID: 21645266
[TBL] [Abstract][Full Text] [Related]
40. Role of PTPRJ genotype in papillary thyroid carcinoma risk.
Iuliano R; Palmieri D; He H; Iervolino A; Borbone E; Pallante P; Cianflone A; Nagy R; Alder H; Calin GA; Trapasso F; Giordano C; Croce CM; de la Chapelle A; Fusco A
Endocr Relat Cancer; 2010 Dec; 17(4):1001-6. PubMed ID: 20823296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
